NCT02175927View on ClinicalTrials.gov

High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection

PHASE4CompletedINTERVENTIONAL

Enrollment

312

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Helicobacter Pylori Treatment Failure

Interventions

DRUG

Lansoprazole

antisecretory drug of each quadruple therapy

DRUG

Bismuth Potassium Citrate

one component of each quadruple therapy

DRUG

Metronidazole

antibiotic of each quadruple therapy

DRUG

Amoxicillin

antibiotic of high dose amoxicillin based quadruple therapy

DRUG

Tetracycline

antibiotic of classical quadruple therapy

Trial Locations (1)

200127

Shanghai Renji Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai

All Listed Sponsors

lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT02175927 - High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter